Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed ...

As the prospect of a viable vaccine for Lyme disease approaches, experts feared that Health Secretary Robert F. Kennedy, ...

A new vaccine from companies Pfizer and Valneva meant to prevent Lyme disease may be one step closer to approval.

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

A roundtable on diagnostics and clinical needs of Lyme disease patients, clinicians and researchers, convened Dec. 15, 2025, ...

Lyme disease remains the most common tickborne illness in Minnesota and across the United States. Symptoms can appear three ...

A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...

With the rise in Lyme disease cases in the US, it is increasingly important to stay current with the latest treatment ...